Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (563)	1/24/2000 5:37:00 PM
From: Torben Noerup Nielsen	Respond to of 52153

Mike, Elan is an interesting stock. Go take a good look at what they own. I'd say they're partially a biotech VC company :-) They've taken stakes in a number of smaller companies. In some cases, they've bought out companies. Note that they own at least 17% of Ligand. Note also that in todays baby-correction, Elan held up quite well. On a TA basis, I think they just turned the corner and you should see some upwards movement now. It could be significant if there's a takeover in the works. They're still small enough to be easily bought by some of the sharks and they've got a portfolio that's worth looking at. One possible scenario is a buyout of Elan along with a buyout of Ligand..... Could be an interesting deal. Pure speculation of course. Thanks, Torben